We propose a new bioartificial liver (BAL) system equipped with a high performance hemodialyzer to act as an immunoisolation device. We discuss the design of the BAL system using a mathematical kinetic model with the experimentally obtained mass-transfer performances of various hemodialyzers. The mass transfer resistances of the hemodialyzers did not adversely influence the ammonia-removal and bioactive-substance-supply performances of the BAL system. A suitable hemodialyzer for the BAL system is available even at present using an engineering design. The remaining problems to be overcome before realizing clinical use of the BAL system are to increase the rate constant of the first order reaction of the BAL for ammonia metabolism and to develop a new method of blood access that can be used safely with long term reliability at a high blood flow rate (ca. 556 ml/min).
GerlachJ.C.Development of a hybrid liver support system: A review. Int J Artif Organs1996; 19: 645–54.
2.
KasaiS., SawaM., MitoM.Is bioartificial liver clinically applicable? A historic review of biological artificial liver support systems. Artif Organs1994; 18: 348–54.
3.
CatapanoG., De BartoloL.Importance of the kinetic characterization of liver cell metabolic reactions to the design of hybrid liver support devices. Int J Artif Organs1996; 19: 670–6.
4.
IwataH., ParkY.G., IkadaY.Importance of the extracorporeal circulation rate in a bioartificial liver. Mater Sci Eng C1998; 6: 235–43.
5.
OhshimaN., ShiotaM., KusanoH., WadaG., TsunetsuguT., OokawaK., YanagiK.Kinetic analyses of the performance of a hybrid-type artificial liver support system utilizing isolated hepatocytes. Mater Sci Eng1994; C1: 79–85.
6.
YanagiK., OokawaK., MizunoS., OhshimaN.Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a hydrogel. Trans ASAIO1989; 35: 570–2.
KasaiS., KakisawaA., MitoM., TeradaR., SuzukiJ., TanzawaH.Studies of hybrid artificial liver-treatment of galactosamine induced hepatic failure dog by a metabolic support device using hepatocytes. Jpn J Artif Organs1987; 16: 912–5 (in Japanese).
9.
MatsushitaT., IjimaH., WadaS., FunatsuK.Estimation of the performance of a PUF/spheroid packed-bed type artificial liver by using an extracorporeal circulation with hepatic failure rats. Jpn J Artif Organs1995; 24: 815–20.
10.
GerlachJ., JörresA., TrostO., HoleO., VienkenJ., CourtneyJ.M., GahlG.M., NeuhausP.Side effects of hybrid liver support therapy: TNF-α liberation in pigs, associated with extracorporeal bioreactors. Int J Artif Organs1993; 16: 604–8.
11.
KellyJ.H., SussmanN.L.The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure. ASAIO J1994; 40: 83–5.
12.
IwataH., SajikiT., MaedaH., ParkY.G., ZhuB., SatohS., UesugiT., IkaiI., YamaokaY., IkadaY.In vitro evaluation of metabolic functions of a bioartificial liver. ASAIO J1999; 45: 299–306.
HoofnagleJ.H., CarithersR.L.Jr., ShapiroC., AscherN.Fulminant hepatic failure: Summary of a workshop. Hepatology1995; 21: 240–52.
15.
YanagiK., MiyoshiH., OhshimaN.A high-density culture of hepatocytes using porous substrate for use as a bioartificial liver. Int J Artif Organs1999; 2: 124–8.
16.
ShinzatoT., KobayakawaH., MaedaK.Comparison of various treatment modes in terms of beta 2-microglobulin removal: Hemodialysis, hemofiltration, and push/pull HDF. Artif Organs1989; 13: 66–70.
17.
MichaelsA.S.Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices. Trans Am Soc Artif Intern Organs1966; 12: 387–92.
18.
TakesawaS.Mass transfer mechanism of solutes with small and middle molecular weight in artificial kidney. Doctoral Dissertation, Waseda University, Tokyo, 1983: 64 (in Japanese).
19.
NordmeierE.Static and dynamic light-scattering solution behavior of pullulan and dextran in comparison. J Phys Chem1993; 97: 5770–85.
20.
WuC.Laser light-scattering characterization of the molecular weight distribution of dextran. Macromolecules1963; 26: 3821–5.
21.
ShaoH.J., BaltusR.E.Effect of solute concentration on hindered diffusion in porous membranes. AIChE J2000; 46: 1307–16.
22.
YanagiK., MiyoshiH., OhshimaN.A compartmental mass transfer model to assess performance of a hybrid-type artificial liver support system. Jpn J Artif Organs1993; 22: 325–9 (in Japanese).
UchinoJ., MatsushitaM.Strategies for the rescue of patients with liver failure. ASAIO J1994; 40: 74–7.
25.
FukudaM., HosoyaN., KanamoriT., SakaiK., NishikidoJ., WatanabeT., FushimiF.Determination of optimal fiber density of conventional and high performance dialyzers. Artif Organs Today1992; 2: 205–14.
26.
KanamoriT., SuzukiY., SakaiK., KuwanaK., NakanishiH.Technical determination of optimal dimensions of high performance dialyzers. Jpn J Artif Organs1993; 22: 64–9 (in Japanese).
27.
YanagiK., TunT., TaniguchiH., TakadaY., FukaoK., OhshimaN.Development of a packed-bed type bioartificial liver -Metabolic performance of a scaled-up reactor utilizing cultured porcine hepatocytes. In: UmakoshiY., ed. Tissue engineering for therapeutic use 6.Amsterdam: Elsevier Science2002; 67–73.
28.
YanagiK., OokawaK., MizunoS., OhshimaN.Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a hydrogel. ASAIO Trans1989; 35: 570–2.
29.
YanagiK., OhshimaN.Improvement of metabolic performance of cultured hepatocytes by high oxygen tension in the atmosphere. Artif Organs2001; 25: 1–6.
